The Delhi high court on Wednesday refused to grant an interim stay on the clinical trial of Covaxin in children in the age group of 2 to 18 years. The court, however, issued notices to the Drugs Controller General of India (DCGI) and others on a plea challenging the DCGI’s nod to Bharat Biotech for conducting clinical trials of Covaxin in children. "A person can offer to do anything only if he/she is capable of understanding the consequences of his/her act. Kumar seeks invocation of Section 81 of Juvenile Justice Act, 2015, for penalizing parents who volunteer their children in hopes of monetary compensation. The petitioner also sought directions to the respondents to produce details of all the 525 children who will be enrolled in the trial.

Source: Hindustan Times May 19, 2021 07:06 UTC